HEALTH● ELEVATED1h ago · Oct 23, 2026, 2:42 PM
Personalised cancer vaccine expected to be approved next year
New Scientist · global
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH28m agoNew Florida counties report dengue cases as statewide total passes 400The HillHEALTH47m agoI have a disease that people are too ashamed to talk aboutBBC AfriqueHEALTH1h agoShare Your Experiences With Medicaid Claims for RepaymentNYT USHEALTH1h agoAmerica’s health insurance model crumbles under the success of modern medicineThe Hill